Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms

    NEXT STORY
    Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
    PREV STORY
    Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Foamix Announces Dosing of First Patient in Phase 3 Acne Studies for Minocycline Foam FMX101

    REHOVOT, Israel, and BRIDGEWATER, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. ...

    author_avatar
    NASDAQ Market News

    Global Microbiome Landscape Publication Analytics 2011-2019

    author_avatar
    NASDAQ Market News

    Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

    Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) PresentedMENLO ...

    author_avatar
    NASDAQ Market News